surgery and glp 1 Metabolic GLP-1 agonists | Blog GLP-1 vs Bariatric Surgery: Which

and as a poster at the 52nd Annual Meeting of the European Association for the Study of Diabetes, Munich, Germany, 1216 September 2016

In the HARMONY-2 (efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide) clinical study, patients were randomized to receive either once-weekly albiglutide (30 mg, titrated up to 50 mg if required for glycemic control) or 10 units of insulin glargine once daily

You can see that the outright ban on the sales of compounded GLP-1 would significantly hurt HIMS growth, to the tune of about $480M in 2026

While some anecdotal reports suggest benefits like reduced inflammation and improved management of certain conditions, I emphasized the necessity for more comprehensive research to fully understand the long-term effects and safety of this practice

In this exclusive report, Cure, a healthcare innovation ecosystem in New York City, and the Deerfield Institute unveil the results of a specialty physician survey, shedding light on their current prescribing of GLP-1RA medications, the challenges they face, and their expectations for future clinical applications of these drugs